A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5365
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older ; day:4 ; month:10 ; year:2022 ; pages:1-9
Bone marrow transplantation ; (4.10.2022), 1-9
- Creator
-
Backhaus, Donata Elisabeth
Brauer, Dominic
Pointner, Rosmarie
Bischof, Lara
Vucinic, Vladan
Franke, Georg-Nikolaus
Niederwieser, Dietger
Platzbecker, Uwe
Jentzsch, Madlen
Schwind, Sebastian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-022-01833-0
- URN
-
urn:nbn:de:101:1-2022122409371802409964
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Backhaus, Donata Elisabeth
- Brauer, Dominic
- Pointner, Rosmarie
- Bischof, Lara
- Vucinic, Vladan
- Franke, Georg-Nikolaus
- Niederwieser, Dietger
- Platzbecker, Uwe
- Jentzsch, Madlen
- Schwind, Sebastian
- SpringerLink (Online service)
Other Objects (12)
Tierexperimentelle Untersuchungen zur Resorbierbarkeit von drei neuentwickelten porösen Biogläsern, Bioglaskeramiken
Azacitidin : prophylaktische Maßnahmen und Therapiemanagement ; Nebenwirkungen erkennen, vermeiden, behandeln
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
A high hematopoietic cell transplantation comorbidity index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
Immunprofil von Patienten mit fortgeschrittenen Myelodysplastischen Syndromen oder Akuten Myeloischen Leukämien unter der gegen CD123 gerichteten Therapie mit Talacotuzumab
Hepatocyte Transplantation: Cell Sheet Technology for Liver Cell Transplantation
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
Methods in cell transplantation
Tierexperimentelle Untersuchungen zur Resorbierbarkeit von drei neuentwickelten porösen Biogläsern, Bioglaskeramiken
Azacitidin : prophylaktische Maßnahmen und Therapiemanagement ; Nebenwirkungen erkennen, vermeiden, behandeln
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
A high hematopoietic cell transplantation comorbidity index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
Immunprofil von Patienten mit fortgeschrittenen Myelodysplastischen Syndromen oder Akuten Myeloischen Leukämien unter der gegen CD123 gerichteten Therapie mit Talacotuzumab
Hepatocyte Transplantation: Cell Sheet Technology for Liver Cell Transplantation
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
Methods in cell transplantation
Tierexperimentelle Untersuchungen zur Resorbierbarkeit von drei neuentwickelten porösen Biogläsern, Bioglaskeramiken
Azacitidin : prophylaktische Maßnahmen und Therapiemanagement ; Nebenwirkungen erkennen, vermeiden, behandeln
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
A high hematopoietic cell transplantation comorbidity index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older
Immunprofil von Patienten mit fortgeschrittenen Myelodysplastischen Syndromen oder Akuten Myeloischen Leukämien unter der gegen CD123 gerichteten Therapie mit Talacotuzumab
Hepatocyte Transplantation: Cell Sheet Technology for Liver Cell Transplantation
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible